Estrone cyanate

Estrone_cyanate.svg

Estrone cyanate is a synthetic estrogen and a derivative of estrone. It is classified as an estrogen ester and is specifically the 3-cyanate ester of estrone. Estrone cyanate is known for its potential use in hormone replacement therapy and other medical applications related to estrogen deficiency.

Chemical Structure and Properties

Estrone cyanate has the chemical formula C19H21NO2. It is derived from estrone, a naturally occurring estrogen, by the addition of a cyanate group at the 3-position of the steroid nucleus. This modification alters the pharmacokinetics and pharmacodynamics of the molecule, potentially affecting its bioavailability and metabolism.

Mechanism of Action

As an estrogen, estrone cyanate binds to and activates the estrogen receptors (ERs) in various tissues. This activation leads to the modulation of gene expression and the regulation of numerous physiological processes, including the development and maintenance of female secondary sexual characteristics, regulation of the menstrual cycle, and maintenance of bone density.

Medical Uses

Estrone cyanate has been investigated for its use in hormone replacement therapy (HRT) for the treatment of symptoms associated with menopause, such as hot flashes, vaginal atrophy, and osteoporosis. It may also be used in the management of hypoestrogenism due to various causes, including ovarian failure and hypogonadism.

Pharmacokinetics

The pharmacokinetics of estrone cyanate involve its absorption, distribution, metabolism, and excretion. As an ester of estrone, it is likely hydrolyzed in the body to release the active hormone, estrone. The exact pharmacokinetic profile, including its half-life, bioavailability, and metabolic pathways, would depend on the specific formulation and route of administration.

Side Effects

Like other estrogens, estrone cyanate may cause side effects, including but not limited to nausea, breast tenderness, headache, and fluid retention. Long-term use of estrogens has been associated with an increased risk of endometrial cancer, breast cancer, and cardiovascular disease. Therefore, the use of estrone cyanate should be carefully monitored by a healthcare provider.

See Also

• Estrone
• Estrogen
• Hormone replacement therapy
• Menopause
• Hypoestrogenism

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian